Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Berlin Heart has enrolled the first patient in the prospective IDE study for its Excor paediatric VAD, a mechanical cardiac support system for critically ill paediatric patients suffering from severe heart failure.
Subscribe to our email newsletter
The multi-center IDE study is designed to evaluate the safety and benefit of using the Excor paediatric VAD to support paediatric patients. The FDA granted conditional approval for the prospective IDE study to begin initially at 10 centers with 10 patients in May 2007.
According to the company, Excor paediatric has been designed as a bridge to transplantation for patients waiting for a suitable donor heart, but has also been used as a bridge to recovery when a patient’s heart was able to recover and work on its own again.
Rolf Kaese, CEO of Berlin Heart, said: “Enrolling the first patient in the Excor paediatric IDE study marks a milestone and brings us one step closer toward obtaining HDE approval.”